Adrian Minson

466 total citations
23 papers, 157 citations indexed

About

Adrian Minson is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Adrian Minson has authored 23 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 10 papers in Genetics. Recurrent topics in Adrian Minson's work include Lymphoma Diagnosis and Treatment (18 papers), CAR-T cell therapy research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Adrian Minson is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), CAR-T cell therapy research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Adrian Minson collaborates with scholars based in Australia, New Zealand and Hungary. Adrian Minson's co-authors include Michael Dickinson, Piers Blombery, Mary Ann Anderson, Sam Radford, Rinaldo Bellomo, Elliott Ridgeon, Andrew Casamento, Johan Mårtensson, Paul J. Young and Sam Grigg and has published in prestigious journals such as Blood, Frontiers in Immunology and British Journal of Haematology.

In The Last Decade

Adrian Minson

19 papers receiving 155 citations

Peers

Adrian Minson

PFM

ONCOL

GENET

NEURO

Sergio Fava Italy

Mansoor Noorani United States

Yoshiaki Usui Japan

Asu Fergün Yılmaz Türkiye

P Cony-Makhoul France

Angela Gueli Italy

Fabiana Gentilini Italy

Edyta Subocz Poland

Jasmin Mettler Germany

Concepción Nicolás Spain

Sergio Fava Italy

Adrian Minson

77 ×0.9

PFM

75 ×0.9

ONCOL

46 ×1.2

GENET

37 ×1.0

NEURO

11 ×0.4

Citations per year, relative to Adrian Minson Adrian Minson (= 1×) peers Sergio Fava

Countries citing papers authored by Adrian Minson

Since Specialization

Citations

This map shows the geographic impact of Adrian Minson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Minson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Minson more than expected).

Fields of papers citing papers by Adrian Minson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Minson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Minson. The network helps show where Adrian Minson may publish in the future.

Co-authorship network of co-authors of Adrian Minson

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Minson. A scholar is included among the top collaborators of Adrian Minson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Minson. Adrian Minson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minson, Adrian & Michael Dickinson. (2025). New bispecific antibodies in diffuse large B-cell lymphoma. Haematologica. 110(7). 1483–1499. 1 indexed citations

Robertson, Molly, Christine Khoo, Jonathan Segal, et al.. (2025). Enterocolitis associated with glofitamab—First report and clinicopathological findings in three cases. British Journal of Haematology. 206(6). 1654–1658.

Minson, Adrian, et al.. (2025). Bispecific antibody combination therapies in diffuse large B‐cell lymphoma. British Journal of Haematology. 208(1). 13–24.

Robertson, Molly, et al.. (2024). Preparing Nurses for CD20-CD3 Bispecific Antibody Treatment in Patients With Non-Hodgkin Lymphoma: A Scoping Review of Adverse Events and Management Strategies From Early Phase and Pivotal Trials. Cancer Nursing. 49(2). E188–E202. 1 indexed citations

Minson, Adrian & Michael Dickinson. (2024). Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement. Leukemia & lymphoma. 65(5). 546–547. 1 indexed citations

Özcan, Muhıt, Maria Bouzani, Zsolt Nagy, et al.. (2024). Phase 3, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared with Rituximab Plus Gemcitabine and Oxaliplatin in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Blood. 144(Supplement 1). 4502.1–4502.1. 2 indexed citations

Dowling, Mark R., Daniel Fernández-García, Adrian Minson, et al.. (2024). Bridging Radiotherapy to Axicabtagene Ciloleucel (axi-cel) Is Associated with Favourable Outcomes for Large B-Cell Lymphoma (LBCL) in Third-Line and Beyond: An Australian Single-Centre Real-World Experience. Blood. 144(Supplement 1). 4511–4511.

Grigg, Sam, et al.. (2024). Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high. British Journal of Haematology. 205(1). 122–126. 10 indexed citations

Minson, Adrian, Nada Hamad, Dipti Talaulikar, et al.. (2023). Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom. British Journal of Haematology. 204(2). 548–554. 3 indexed citations

10.

Dickinson, Michael, Judith Trotman, Leanne Berkahn, et al.. (2023). PEMBROLIZUMAB AS FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD‐INELIGIBLE PATIENTS, ALLOWS SUBSEQUENT THERAPY, AND GIVES ADEQUATE SURVIVAL.. Hematological Oncology. 41(S2). 160–161. 6 indexed citations

11.

Lew, Thomas E., Adrian Minson, Michael Dickinson, et al.. (2023). Treatment approaches for patients with TP53-mutated mantle cell lymphoma. The Lancet Haematology. 10(2). e142–e154. 17 indexed citations

12.

Dickinson, Michael, Leanne Berkahn, Judith Trotman, et al.. (2023). P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.. HemaSphere. 7(S3). e691267e–e691267e.

13.

Minson, Adrian, Nada Hamad, Chan Y. Cheah, et al.. (2022). Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study. Blood. 140(Supplement 1). 181–183. 6 indexed citations

14.

Wellard, Cameron, Dipti Talaulikar, Colm Keane, et al.. (2022). Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry. Leukemia & lymphoma. 64(3). 621–627. 1 indexed citations

15.

Minson, Adrian, Michael S. Hofman, & Michael Dickinson. (2021). A PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse. Leukemia & lymphoma. 63(1). 1–4. 2 indexed citations

16.

Minson, Adrian, et al.. (2021). CAR-T cell therapy: practical guide to routine laboratory monitoring. Pathology. 53(3). 408–415. 15 indexed citations

17.

Minson, Adrian, Nada Hamad, Jason Butler, et al.. (2020). A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC). Blood. 136(Supplement 1). 34–35. 4 indexed citations

18.

Wight, Joel, Colm Keane, Anna Johnston, et al.. (2019). Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. British Journal of Haematology. 187(2). 174–184. 23 indexed citations

19.

Bernal, Jamie Lopez, Tahereh Noori, Adrian Minson, et al.. (2018). Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing. Frontiers in Immunology. 9. 529–529. 14 indexed citations

20.

Casamento, Andrew, Adrian Minson, Sam Radford, et al.. (2016). A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrest. Resuscitation. 106. 83–88. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact